-+ 0.00%
-+ 0.00%
-+ 0.00%

East Asia Pharmaceutical announced that the company recently received the “Drug Registration Certificate” for trimebutine maleate tablets approved and issued by the State Drug Administration. The specifications are 0.2 g and 0.1 g. The registration classification is 3 types of chemicals. The certificate numbers are 2026S04093 and 2026S04094. The drug approval numbers are Sinopharm H20266546 and Sinopharm H20266547, respectively. This drug is a digestive medicine. It can be used to relieve gastrointestinal discomfort such as bloating, abdominal pain, and hiccups caused by chronic gastritis, and treat irritable bowel syndrome. According to relevant data, the sales volume of trimebutine maleate tablets in 2025 is about 280 million yuan in medical institutions and physical pharmacies nationwide, and global sales are about 210 million US dollars.

智通财经·11/17/2026 07:41:23
语音播报
East Asia Pharmaceutical announced that the company recently received the “Drug Registration Certificate” for trimebutine maleate tablets approved and issued by the State Drug Administration. The specifications are 0.2 g and 0.1 g. The registration classification is 3 types of chemicals. The certificate numbers are 2026S04093 and 2026S04094. The drug approval numbers are Sinopharm H20266546 and Sinopharm H20266547, respectively. This drug is a digestive medicine. It can be used to relieve gastrointestinal discomfort such as bloating, abdominal pain, and hiccups caused by chronic gastritis, and treat irritable bowel syndrome. According to relevant data, the sales volume of trimebutine maleate tablets in 2025 is about 280 million yuan in medical institutions and physical pharmacies nationwide, and global sales are about 210 million US dollars.